Remdesivir is an investigational drug being studied to treat coronavirus infection, also known as COVID-19. It has not been approved by the FDA for general use. However, the FDA is now allow ingremdesivir to be used in human studies and for emergency use in certain hospitalized patients. More information should be provided by the doctor from either the Informed Consent form for a study or the FDA Fact Sheet for Patient sand Parents/Caregivers for emergency use.
Remdesivir is given by injection into a vein usually once daily for 5 to 10 days. It is infused over a period ranging from 30 minutes to 2 hours.